All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Phaco wound burn occurs when the heat generated by the phaco probe—both through mechanical energy and friction—results in thermal damage to surrounding corneal tissue. Two physicians discussed this rare complication.
➤ FDA issues complete response letter for bevacizumab for retinal diseases ➤ First patient dosed in study evaluating X-linked retinoschisis ➤ Gene therapy study for Leber hereditary optic neuropathy begins dosing ➤ Update on rare retinal vasculitis events associated with GA treatment ➤ Eye drop recall grows ➤ ASCRS news and events
➤ FDA approves high-dose aflibercept ➤ Positive results in Phase 1 trial for cultivated autologous limbal epithelial cells ➤ Study: data from eye scans detect Parkinson’s disease years before clinical presentation ➤ Phase 2/3 study to evaluate persistent corneal epithelial defect treatment ➤ Phase 3 study offers results with aflibercept biosimilar ➤ ASCRS news and events
➤ First implantations for clinical trials for investigational IOLs ➤ Phase 2 clinical trial for wet AMD treatment completes enrollment ➤ Two-year results from trial showcase vision gains in wet AMD at extended aflibercept dosing intervals ➤ Acquisition update ➤ ASCRS news and events
➤ Positive Phase 3 results from trial investigating ocular pain, inflammation treatment ➤ Study evaluates use of sustained-release drug during Medicare pass-through program ➤ FDA approves treatment for geographic atrophy ➤ Dementia ‘much higher’ in patients with visual problems ➤ ASCRS news and events
The University of Southern California ophthalmology residents reviewed this article from a recent issue of the Journal of Cataract & Refractive Surgery.
➤ FDA approves first treatment targeting Demodex ➤ Phase 1 study compares mechanical dry eye treatment to drop therapy ➤ Topical gene therapy for rare ocular surface condition ➤ Glaucoma drug licensed for commercialization in U.S. ➤ ASCRS news and events
➤ Study: low-dose atropine doesn’t slow myopia progression ➤ Adverse events reported after use of FDA-approved geographic atrophy drug ➤ Phase 1 data for synthetic cannabinoid being investigated for glaucoma ➤ Enrollment complete in study evaluating topical diabetic retinopathy therapy ➤ Enrollment update for Phase 2b trial that could reduce AMD treatment burden ➤ ASCRS news and events
This article recaps the 2023 Richard L. Lindstrom, MD, Lecture, titled “Glaucoma Surgery: Taking it to the Next Level,” given by Marlene Moster, MD, as well as the other presentations in the session, given by Cathleen McCabe, MD, Francis Mah, MD, and Daniel Chang, MD.
The cataract patient who has had prior refractive surgery requires extra considerations in terms of consultations/patient expectations, IOL selection, formulas, use of intraoperative technologies, and postoperative potential. Two experts provided their thoughts on the modern management of these cataract patients.
Get the latest ophthalmology news delivered to your inbox every Friday.